Maart 2023: Abemaciclib (Verzenio, Eli Lilly and Company) en endokriene terapie (tamoxifen of 'n aromatase-inhibeerder) is deur die Food and Drug Administration (FDA) goedgekeur vir die adjuvante behandeling van volwasse pasiënte met ..
Maart 2023: Studietipe: Intervensionele (Kliniese Proef) Geskatte inskrywing: 30 deelnemers Toekenning: Nvt Intervensiemodel: Opeenvolgende opdragIntervensiemodelbeskrywing: 'n "3+3"-ontwerp word gebruik om Maksimum te bepaal.
SHANGHAI, CHINA, 12 Desember 2022 'n Onafhanklike en kreatiewe biotegnologiemaatskappy genaamd JW Therapeutics (HKEX: 2126) fokus op die ontwikkeling, vervaardiging en verkoop van selimmunoterapieprodukte. By die 64ste Amerikaanse Vereniging ..
Feb 2023: Dostarlimab-gxly (Jemperli, GlaxoSmithKline LLC) was given FDA approval to treat adult patients with mismatch repair deficient (dMMR) recurrent or advanced endometrial cancer that has progressed during or after a prior ..
Augustus 2022: Vir volwasse pasiënte met nie-opereerbare of metastatiese HER2-lae (IHC 1+ of IHC 2+/ISH) borskanker wat voorheen chemoterapie in die metastatiese omgewing ontvang het of 'n siekte-herhaling ervaar het tydens of binne ses.
Maart 2022: Die Food and Drug Administration het olaparib (Lynparza, AstraZeneca Pharmaceuticals, LP) goedgekeur vir die adjuvante behandeling van volwasse pasiënte met skadelike of vermoedelik skadelike kiemlyn BRCA-gemuteerde (gBRCAm) h..
Dec 2021: The following drugs are approved as of date for the treatment of liver cancer:. Please check the prescribing information before taking the drug. Atezolizumab Avastin (Bevacizumab) Bevacizumab Cabometyx (Cabozantinib-S-M..
August 20, 2021: Recently in May, 2021 Lumakras (sotorasib) was approved by the US Food and Drug Administration as the first treatment for adult patients with non-small cell lung cancer who have undergone at least one prior system..
On February 15, 2019, pembrolizumab (KEYTRUDA, Merck) was approved by the Food and Drug Administration for the adjuvant treatment of patients with melanoma with the involvement of lymph node(s) after full resection. The approval ..
Op 6 Februarie 2019, in samewerking met plasma-uitruiling en immuunonderdrukkende behandeling, het die Food and Drug Administration caplacizumab-yhdp (CABLIVI, Ablynx NV) goedgekeur vir volwasse pasiënte met verworwe trombotiese trombositopenie.